# Refine USA, LLC - Inspection Records

Source: https://www.keypedia.com/companies/refine-usa-llc/52f6174e-99ed-4128-9380-d6434537b084

> Inspection records and compliance data for Refine USA, LLC in Jacksonville, Florida. Access full analysis and detailed observations.

---

## Details

- Name: Refine USA, LLC
- FEI Number: 3006033709
- City: Jacksonville
- State: Florida
- Country Name: United States
- Address Line 1: 340 3rd Ave S Ste C
- Zip Code: 32250

## Related Documents

- [483 - Refine USA, LLC - 2023-08-16](https://www.keypedia.com/records/483/refine-usa-llc/028708dd-020f-4e4f-a32b-45868dd37779) — source: FDA, date: August 16, 2023
- [FDA Inspection 1215028 - Refine USA, LLC - 2023-08-16](https://www.keypedia.com/records/fda_inspections/refine-usa-llc/0d54363d-68ef-4fe5-b359-79ed2530f5f7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 16, 2023
- [FDA Inspection 1215028 - Refine USA, LLC - 2023-08-16](https://www.keypedia.com/records/fda_inspections/refine-usa-llc/25957ef7-6a47-46c8-b460-87533d172717) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2023
- [FDA Inspection 1049482 - Refine USA, LLC - 2018-04-18](https://www.keypedia.com/records/fda_inspections/refine-usa-llc/8f893699-8f3d-4230-b4cb-a24bb66f41a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 18, 2018
- [FDA Inspection 1049482 - Refine USA, LLC - 2018-04-18](https://www.keypedia.com/records/fda_inspections/refine-usa-llc/160fbfc8-1f6d-4c9a-ba50-e958a1d6bcbf) — classification: No Action Indicated (NAI), source: FDA, date: April 18, 2018
- [FDA Inspection 852060 - Refine USA, LLC - 2013-10-04](https://www.keypedia.com/records/fda_inspections/refine-usa-llc/fb42ac19-1208-4965-8376-49a7a2d9a726) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 4, 2013
- [FDA Inspection 852060 - Refine USA, LLC - 2013-10-04](https://www.keypedia.com/records/fda_inspections/refine-usa-llc/7095f627-906e-4f7e-9bcd-6c04bea087b6) — classification: No Action Indicated (NAI), source: FDA, date: October 4, 2013

## Related Companies

- [Philips Respironics, Inc.](https://www.keypedia.com/companies/philips-respironics-inc/03ceee46-7a72-4590-8bc4-8033e1503cf3)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [Reading Hospital](https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60)
- [Primus Corporation dba Trinity Biotech](https://www.keypedia.com/companies/primus-corporation-dba-trinity-biotech/df325fd3-9d48-441b-a9f5-54b8401243c5)
- [Ad-Tech Medical Instrument Corporation](https://www.keypedia.com/companies/ad-tech-medical-instrument-corporation/c1ea8550-2f68-45aa-9ec5-c82ec299b425)
- [Everything Sprouts, LLC](https://www.keypedia.com/companies/everything-sprouts-llc/d8ac40b4-d290-4435-b87d-4f3439e94693)
- [National Biological Corp](https://www.keypedia.com/companies/national-biological-corp/2ea6c746-7d5e-43ca-bc6f-ced3c21c9311)
- [Emu Products and Management, Inc. (EPMI)](https://www.keypedia.com/companies/emu-products-and-management-inc-epmi/97a90c26-c25d-4496-8a29-89d886bbc423)
- [Purdue Pharma L.P.](https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346)
- [BURTON MEDICAL](https://www.keypedia.com/companies/burton-medical/4cd7a15c-6124-4d31-8f3f-f3f3c5f38c08)

## Related Officers

- [Alex J. Wild](https://www.keypedia.com/people/alex-j-wild/bb1b66b3-19b9-480e-af0b-f06f8de0d930)
